FDA approves esketamine, the first major depression treatment to reach U.S. market in decades The Food and Drug Administration on Tuesday approved esketamine, the first major depression treatment to hit the U.S. market in decades and a new option for patients who haven’t responded to existing therapies. Esketamine — developed by Johnson & Johnson and […]
Filed under: General Problems | Leave a Comment »